Medicare Expansion
Jake discusses the significance of Medicare's coverage expansion for CGM, highlighting the benefits for type two individuals. The conversation delves into the potential for broader insurance acceptance and improved health outcomes through CGM use in type twos.In this clip
From this podcast

Juicebox Podcast: Type 1 Diabetes
#806 Dexcom G7 Approved By FDA (with Dexcom COO Jake Leach)
Related Questions